Results 121 to 130 of about 121,974 (243)

ARTERIAL SUPPLY OF THE CEREBRAL CORTEX IN CATTLE (Bos primigenius f. dom.)

open access: yesSlovenian Veterinary Research, 2016
Studies of the vascularization of the cerebrum in cattle were performed on 60 cerebral hemispheres received from a meat-processing plant in Bydgoszcz, Poland. The sex of the cattle was not determined.
Benedykt Skoczylas   +4 more
doaj  

Effects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1271-1282, April 2025.
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao   +27 more
wiley   +1 more source

Injection Bias Reduction Techniques in Quantitative Angiography Using Patient-Specific Phantoms of Intracranial Aneurysm [PDF]

open access: yesarXiv
In intracranial aneurysm (IA) treatment, digital subtraction angiography (DSA) monitors device-induced hemodynamic changes. Quantitative angiography (QA) provides more precise assessments but is limited by hand-injection variability. This study evaluates correction methods using in vitro phantoms that mimic diverse aneurysm morphologies and locations ...
arxiv  

Connecting the dots: A narrative review of the relationship between heart failure and cognitive impairment

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi   +6 more
wiley   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

Left Middle Cerebral Artery Stroke

open access: yesStroke: Vascular and Interventional Neurology, 2022
Ari D. Kappel
doaj   +1 more source

Electron microscopic findings predict clinical outcomes in patients with non‐ischaemic cardiomyopathy

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Electron microscopy reveals microstructural alterations in cardiomyocyte nuclei and myofilaments in non‐ischaemic cardiomyopathy (NICM), particularly in dilated cardiomyopathy (DCM). Nevertheless, the correlation between such observations and clinical outcomes, including prognosis and left ventricular reverse remodelling (LVRR), remains ...
Rie Higuchi   +19 more
wiley   +1 more source

BUN‐to‐ALB ratio as an effective predictor of 30 day mortality in ADHF patients in eastern China

open access: yesESC Heart Failure, EarlyView.
Abstract Aims The blood urea nitrogen‐to‐albumin ratio (BAR) is considered a potential indicator for assessing the poor prognosis of heart failure (HF). However, its prognostic value for Chinese patients with acute decompensated HF (ADHF) remains unclear.
Xin Huang   +8 more
wiley   +1 more source

Data-driven modeling and prediction of microglial cell dynamics in the ischemic penumbra [PDF]

open access: yesarXiv
Neuroinflammation immediately follows the onset of ischemic stroke. During this process, microglial cells are activated in and recruited to the tissue surrounding the irreversibly injured infarct core, referred to as the penumbra. Microglial cells can be activated into two distinct phenotypes; however, the dynamics between the detrimental M1 phenotype ...
arxiv  

SGLT2 inhibitor with and without ALDosterone AntagonIst for heart failure with preserved ejection fraction: Design paper

open access: yesESC Heart Failure, EarlyView.
Abstract Background Sodium glucose co‐transporter 2 inhibitors (SGLT2i) and mineralocorticoid receptor antagonists (MRA) reduce heart failure (HF) events in patients with heart failure and mildly reduced or preserved ejection fraction (HFmr/pEF). The randomized comparison of SGLT2i/MRA combination versus SGLT2i or MRA alone requires further testing in ...
João Pedro Ferreira   +26 more
wiley   +1 more source

Home - About - Disclaimer - Privacy